BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2004
View Archived Issues
Depletion of B-cells by humanized anti-CD20 antibody in monkeys
Read More
Abatacept shows promise in the treatment of rheumatoid arthritis
Read More
Enrollment underway in study of WinRho SDF for dengue hemorrhagic fever
Read More
Cangene and DynPort seeking approval of VIG products
Read More
Orphan drug status for Efaproxyn
Read More
South African HIV trial of VGV-1 commences enrollment
Read More
Sculptra receives FDA approval for lipoatrophy
Read More
Funding at Pepgen to support advancement of Tauferon
Read More
New KSP inhibitors jointly reported by GSK and Cytokinetics
Read More
Micrologix Biotech and Strata enter agreement for MBI-226
Read More
New histamine H3 ligands and their use in obesity and other disorders
Read More
Sigma-Tau presents novel agents for diabetes, obesity, etc.
Read More
Orphan drug designation for ambrisentan for PAH
Read More
Active Pass researchers describe new antiamyloidogenic agents
Read More
Pierre Fabre and Merck & Co. sign agreement for F-50035
Read More
Novel CD80 antagonists and their use claimed by Active Biotech
Read More
Phase I study begins of IL-13-PE38QQR for newly diagnosed malignant glioma
Read More
Novel 5-HT reuptake inhibitors and 5-HT1A/5-HT2A agonists identified at Merck KGaA
Read More
NR2B-selective NMDA antagonists newly discovered at Pfizer
Read More
SBIR award supports research into proteoglycans in Alzheimer's at ProteoTech
Read More
Enrollment completed in phase II study of octreotide implant
Read More
Series B financing at Ceregene
Read More
BAY-43-9006 receives European orphan drug status for renal cell carcinoma
Read More
Emisphere selects formulation of oral heparin
Read More
AX-200 set to enter phase II for stroke
Read More
GSK provides notice to Inex to terminate topotecan agreement
Read More
Cymbalta approved for major depressive disorder
Read More
Liver-selective glucocorticoid antagonist for type 2 diabetes therapy
Read More
Antioxidant compound effective against arteriosclerosis in rodent allograft model
Read More
Novel immunotherapeutic approach to cancer therapy with dendritic cell crosslinking antibody
Read More
Exploring effective natural products for Alzheimer therapy
Read More